Maria V Selvadurai|Justin R Hamilton - JoVE Visualize

Showing results (21-30 of 52) with videos related to

Pageof 6

Sort By:

Journal of Thrombosis and Haemostasis : JTH|July 3, 2025

Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet functionMarie-Christine Morel-Kopp, Marie Levade, Lucinda Beutler, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005

Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanismsXiao Su, Eric Camerer, Justin R Hamilton, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosisErik R Vandendries, Justin R Hamilton, Shaun R Coughlin, et al.

Platelets|August 22, 2020

Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902Simeng Li, Volga Tarlac, Roberto B I Christanto, et al.

Journal of Medicinal Chemistry|September 21, 2016

Class II Phosphoinositide 3-Kinases as Novel Drug TargetsMarco Falasca, Justin R Hamilton, Maria Selvadurai, et al.

Journal of Thrombosis and Haemostasis : JTH|January 17, 2022

Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopeniaChristine S M Lee, Maria V Selvadurai, Leonardo Pasalic, et al.

Plos One|October 28, 2016

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse PlateletsShauna L French, Antonia C Paramitha, Mitchell J Moon, et al.

Science Translational Medicine|July 29, 2020

Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activationMaria V Selvadurai, Mitchell J Moon, Simon J Mountford, et al.

ACS Medicinal Chemistry Letters|January 16, 2015

Class II but Not Second Class-Prospects for the Development of Class II PI3K InhibitorsSimon J Mountford, Zhaohua Zheng, Krithika Sundaram, et al.

Platelets|March 5, 2016

Combined deficiency of PI3KC2α and PI3KC2β reveals a nonredundant role for PI3KC2α in regulating mouse platelet structure and thrombus stabilityClaire Petitjean, Natasha M Setiabakti, Jessica K Mountford, et al.

Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:

Pageof 6

Journal of Thrombosis and Haemostasis : JTH|July 3, 2025

Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet functionMarie-Christine Morel-Kopp, Marie Levade, Lucinda Beutler, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005

Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanismsXiao Su, Eric Camerer, Justin R Hamilton, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosisErik R Vandendries, Justin R Hamilton, Shaun R Coughlin, et al.

Platelets|August 22, 2020

Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902Simeng Li, Volga Tarlac, Roberto B I Christanto, et al.

Journal of Medicinal Chemistry|September 21, 2016

Class II Phosphoinositide 3-Kinases as Novel Drug TargetsMarco Falasca, Justin R Hamilton, Maria Selvadurai, et al.

Journal of Thrombosis and Haemostasis : JTH|January 17, 2022

Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopeniaChristine S M Lee, Maria V Selvadurai, Leonardo Pasalic, et al.

Plos One|October 28, 2016

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse PlateletsShauna L French, Antonia C Paramitha, Mitchell J Moon, et al.

Science Translational Medicine|July 29, 2020

Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activationMaria V Selvadurai, Mitchell J Moon, Simon J Mountford, et al.

ACS Medicinal Chemistry Letters|January 16, 2015

Class II but Not Second Class-Prospects for the Development of Class II PI3K InhibitorsSimon J Mountford, Zhaohua Zheng, Krithika Sundaram, et al.

Platelets|March 5, 2016

Combined deficiency of PI3KC2α and PI3KC2β reveals a nonredundant role for PI3KC2α in regulating mouse platelet structure and thrombus stabilityClaire Petitjean, Natasha M Setiabakti, Jessica K Mountford, et al.

Pageof 6